Finger, RP;
Schmitz-Valckenberg, S;
Schmid, M;
Rubin, GS;
Dunbar, H;
Tufail, A;
Crabb, DP;
... MACUSTAR Consortium, .; + view all
(2019)
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration.
Ophthalmologica
, 241
(2)
pp. 61-72.
10.1159/000491402.
Preview |
Text
Rubin VoR 491402.pdf - Published Version Download (346kB) | Preview |
![[thumbnail of Supplementary files]](https://discovery.ucl.ac.uk/style/images/fileicons/archive.png) |
Archive (Supplementary files)
Finger_7016390.zip Download (228kB) |
Abstract
PURPOSE: Currently, no outcome measures are clinically validated and accepted as clinical endpoints by regulatory agencies for drug development in intermediate age-related macular degeneration (iAMD). The MACUSTAR Consortium, a public-private research group funded by the European Innovative Medicines Initiative intends to close this gap. PROCEDURES: Development of study protocol and statistical analysis plan including predictive modelling of multimodal endpoints based on a review of the literature and expert consensus. RESULTS: This observational study consists of a cross-sectional and a longitudinal part. Functional outcome measures assessed under low contrast and low luminance have the potential to detect progression of visual deficit within iAMD and to late AMD. Structural outcome measures will be multimodal and investigate topographical relationships with function. Current patient-reported outcome measures (PROMs) are not acceptable to regulators and may not capture the functional deficit specific to iAMD with needed precision, justifying development of novel PROMs for iAMD. The total sample size will be n = 750, consisting mainly of subjects with iAMD (n = 600). CONCLUSIONS: As clinical endpoints currently accepted by regulators cannot detect functional loss or patient-relevant impact in iAMD, we will clinically validate novel candidate endpoints for iAMD.
| Type: | Article |
|---|---|
| Title: | MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration |
| Location: | Switzerland |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1159/000491402 |
| Publisher version: | https://doi.org/10.1159/000491402 |
| Language: | English |
| Additional information: | This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. |
| Keywords: | Clinical endpoint, Disease progression, Intermediate age-related macular degeneration, Patient-reported outcomes, Structure-function correlation |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10055645 |
Archive Staff Only
 |
View Item |
